drug-development
Latest stories covering drug-development, with summaries and links to related coverage.
4 articles · page 1 of 1
Connected topics
The Sloppification of Peptides
opinion
4 min read
Gray-market peptide sellers and review sites are increasingly using AI-generated websites, testimonials, and forum posts to appear credible. Peptides are short amino-acid chains that generally must be injected or delivered nasally because digestion breaks them down, and demand for them has created a market of suppliers whose quality and legitimacy can be difficult to verify. Qingdao Sigma, a frequently recommended peptide seller, displays low prices, purported laboratory testing, card payments, and favorable reviews. Its apparent Trustpilot page is hosted on its own site rather than Trustpilot, and the reviews were identified as AI-generated. CompoundTalk, a peptide-review site with a “Verified Vendors” forum, contains AI-generated posts, including a thread about Qingdao Sigma. An analysis using Claude found that CompoundTalk was hosted by Moldova-based AlexHost; listed 20 Chinese raw-peptide vendors; and had recurring data anomalies, including exactly five posts per forum thread, 985 threads dated before the domain registration, and posts predating their supposed authors’ registrations. CompoundTalk and the peptide-analysis site PeptideMeter were registered 13 minutes apart through the same registrar and share the same Cloudflare DNS-server pair. CompoundTalk’s robots.txt explicitly permits LLM crawlers, while the site sells vendor-feature packages and says sponsorship does not affect moderation or reviews. The site’s operator could be seeking visibility in AI-generated recommendations, although that intent is not independently established.
Copper transport drug restores memory and clears toxic Alzheimer's proteins
research
1 min read
A new drug targeting copper transport has been shown to restore memory and eliminate toxic proteins associated with Alzheimer's disease. This treatment offers potential therapeutic benefits for cognitive decline in Alzheimer's patients.
New drug 'functionally cures' many hepatitis B virus infections
research
5 min read
An experimental drug combined with standard antivirals has achieved a "functional cure" for 19% of participants in two trials involving chronic hepatitis B virus (HBV) infections. These results indicate that individuals can control the virus naturally without further treatment after a 6-month regimen.
Peptides: where to begin?
opinion
7 min read
Peptides are short chains of amino acids that are gaining attention as new drugs available for mail order. The term "peptide" can have different meanings in scientific contexts compared to popular usage.